Arkolith/Insider Trading/SILO/Form 4

Weisblum Eric

CEO and President, DirectorSilo Pharma, Inc. (SILO) · full profile →Form 4 · filed Dec 7, 2023
Net Buying
Open-Market Buys
$1K
Open-Market Sells
$0
Net Open-Market Flow
$1K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 7, 2023Buy(P)324$1.36$441168K
Dec 6, 2023Buy(P)76$1.34$102168K
Dec 5, 2023Buy(P)600$1.39$834168K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-23-094145) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML